Novartis (NVS) released its Q2 2018 earnings on July 18 and surpassed Wall Street analysts’ estimates for revenues and EPS. It reported revenues of $13.2 billion and EPS of $1.29, which compares to the estimated EPS of $1.28 on revenues of $13 billion.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,